• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名4岁男孩的多发性硬化症:病例报告及文献综述

Multiple sclerosis in a 4-year-old boy: a case report and literature review.

作者信息

Arkar Ula, Vipotnik Vesnaver Tina, Osredkar Damjan, Perković Benedik Mirjana, Bizjak Neli

机构信息

Department of Child, Adolescent and Developmental Neurology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Department of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

出版信息

Front Neurol. 2024 Mar 22;15:1359938. doi: 10.3389/fneur.2024.1359938. eCollection 2024.

DOI:10.3389/fneur.2024.1359938
PMID:38585366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10996918/
Abstract

Pediatric onset multiple sclerosis (POMS) in the very young is a very rare entity and presents a difficult diagnostic challenge due to overlapping signs and symptoms with other diseases. We present a 4-year-old boy who initially presented with right-sided hemiparesis and demyelinating lesions on MRI. Follow-up MRI examinations 3 and 6 months later revealed new demyelinating lesions. Ten months after initial presentation, he presented with right-sided hemiparesis, central facial nerve palsy on the right side and new demyelinating lesions on MRI. Two clinical events and new MRI lesions on follow-up MRIs confirmed the diagnosis of POMS. He was treated with rituximab and experienced no further relapses or radiological progression during the follow-up period.

摘要

极幼年起病的儿童多发性硬化症(POMS)是一种非常罕见的病症,由于其体征和症状与其他疾病重叠,因此在诊断上面临挑战。我们报告一名4岁男孩,其最初表现为右侧偏瘫,MRI显示有脱髓鞘病变。3个月和6个月后的随访MRI检查发现了新的脱髓鞘病变。首次就诊10个月后,他再次出现右侧偏瘫、右侧中枢性面神经麻痹,MRI显示有新的脱髓鞘病变。两次临床事件以及随访MRI上出现的新病变证实了POMS的诊断。他接受了利妥昔单抗治疗,在随访期间未出现进一步复发或影像学进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/be073405b684/fneur-15-1359938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/efab09aef6cf/fneur-15-1359938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/0157b43a1026/fneur-15-1359938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/d2163193a4c3/fneur-15-1359938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/be073405b684/fneur-15-1359938-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/efab09aef6cf/fneur-15-1359938-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/0157b43a1026/fneur-15-1359938-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/d2163193a4c3/fneur-15-1359938-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa96/10996918/be073405b684/fneur-15-1359938-g004.jpg

相似文献

1
Multiple sclerosis in a 4-year-old boy: a case report and literature review.一名4岁男孩的多发性硬化症:病例报告及文献综述
Front Neurol. 2024 Mar 22;15:1359938. doi: 10.3389/fneur.2024.1359938. eCollection 2024.
2
Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.未确诊的强直性脊柱炎病例中的血清阳性视神经脊髓炎:一个神经风湿病学难题
Qatar Med J. 2022 Jul 7;2022(3):29. doi: 10.5339/qmj.2022.29. eCollection 2022.
3
Inflammatory activity following motor progression due to critical CNS demyelinating lesions.因中枢神经系统关键脱髓鞘病变导致运动进展后的炎症活动。
Mult Scler. 2021 Jun;27(7):1037-1045. doi: 10.1177/1352458520948745. Epub 2020 Aug 19.
4
Balo's concentric sclerosis: An atypical demyelinating disease in pediatrics.巴洛同心圆性硬化:一种儿科非典型脱髓鞘疾病。
Mult Scler Relat Disord. 2020 Sep;44:102198. doi: 10.1016/j.msard.2020.102198. Epub 2020 May 22.
5
Eight-and-a-half syndrome as the first presentation of multiple sclerosis in an Asian male: a case report.以 8 个半月综合征为首发表现的亚洲男性多发性硬化症 1 例报告
J Med Case Rep. 2023 Mar 6;17(1):99. doi: 10.1186/s13256-022-03699-8.
6
[Multiple sclerosis and acute disseminated encephalomyelitis in children: a difficult diagnostic differentiation. Report of a young boy with early onset of the disease].儿童多发性硬化症与急性播散性脑脊髓炎:难以鉴别的诊断。一名疾病早发小男孩的病例报告
Pediatr Med Chir. 2004 May-Jun;26(3):198-200.
7
Atypical clinical and radiological presentation of multiple sclerosis: A case report.多发性硬化症的非典型临床和放射学表现:一例报告
Mult Scler Relat Disord. 2020 Nov;46:102457. doi: 10.1016/j.msard.2020.102457. Epub 2020 Aug 22.
8
Rituximab use in pediatric central demyelinating disease.利妥昔单抗在儿童中枢性脱髓鞘疾病中的应用。
Pediatr Neurol. 2014 Jul;51(1):114-8. doi: 10.1016/j.pediatrneurol.2014.02.007. Epub 2014 Feb 15.
9
Glucocorticoid-dependent multiple sclerosis overlapping anti-NMDA receptor encephalitis: a case report and literature review update.糖皮质激素依赖性多发性硬化重叠抗 NMDA 受体脑炎:病例报告及文献复习更新。
Neurol Sci. 2024 Jan;45(1):83-92. doi: 10.1007/s10072-023-07034-x. Epub 2023 Sep 18.
10
A Case Report of Pediatric Patient with Tuberous Sclerosis and Radiologically Isolated Syndrome.一例结节性硬化症合并放射学孤立综合征患儿的病例报告
J Clin Med. 2023 May 5;12(9):3284. doi: 10.3390/jcm12093284.

本文引用的文献

1
Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes.重新审视抗抗体相关性脱髓鞘综合征时代小儿多发性硬化的特征。
Eur J Paediatr Neurol. 2022 Nov;41:8-18. doi: 10.1016/j.ejpn.2022.08.006. Epub 2022 Sep 1.
2
Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria.血清 MO G-IgG 在符合多发性硬化症诊断标准的儿童中。
Mult Scler. 2022 Oct;28(11):1697-1709. doi: 10.1177/13524585221093789. Epub 2022 May 17.
3
Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis.
疾病修饰疗法的益处与风险的演变:关于将逐步降级作为多发性硬化症患者治疗范例的观点
Front Neurol. 2022 Jan 25;12:799138. doi: 10.3389/fneur.2021.799138. eCollection 2021.
4
Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment.儿童多发性硬化症:鉴别诊断、预后及疾病修正治疗
CNS Drugs. 2022 Jan;36(1):45-59. doi: 10.1007/s40263-021-00887-w. Epub 2021 Dec 23.
5
What does first-line therapy mean for paediatric multiple sclerosis in the current era?当前时代,儿科多发性硬化症的一线治疗方法是什么?
Mult Scler. 2021 Nov;27(13):1970-1976. doi: 10.1177/1352458520937644. Epub 2020 Jul 7.
6
Rituximab in patients with pediatric multiple sclerosis and other demyelinating disorders of the CNS: Practical considerations.利妥昔单抗在儿科多发性硬化症和其他 CNS 脱髓鞘疾病患者中的应用:实际考虑。
Mult Scler. 2021 Oct;27(12):1814-1822. doi: 10.1177/1352458520932798. Epub 2020 Jun 19.
7
Real-World Effectiveness of Initial Disease-Modifying Therapies in Pediatric Multiple Sclerosis.真实世界中初始疾病修正疗法在儿科多发性硬化症中的疗效。
Ann Neurol. 2020 Jul;88(1):42-55. doi: 10.1002/ana.25737. Epub 2020 May 14.
8
Newer Treatment Approaches in Pediatric-Onset Multiple Sclerosis.儿童起病型多发性硬化症的新型治疗方法
Curr Treat Options Neurol. 2019 Sep 27;21(10):50. doi: 10.1007/s11940-019-0592-z.
9
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.利妥昔单抗相关低丙种球蛋白血症与儿科自身免疫性疾病。
Pediatr Rheumatol Online J. 2019 Aug 28;17(1):61. doi: 10.1186/s12969-019-0365-y.
10
Clinical trials of disease-modifying agents in pediatric MS: Opportunities, challenges, and recommendations from the IPMSSG.儿科多发性硬化症疾病修饰治疗药物的临床试验:国际小儿多发性硬化症研究组的机遇、挑战和建议。
Neurology. 2019 May 28;92(22):e2538-e2549. doi: 10.1212/WNL.0000000000007572. Epub 2019 May 1.